As of 2026-05-26, the EV/EBITDA ratio of Shenzhen Bioeasy Biotechnology Co Ltd (300942.SZ) is 128.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300942.SZ's latest enterprise value is 3,024.02 mil CNY. 300942.SZ's TTM EBITDA according to its financial statements is 23.61 mil CNY. Dividing these 2 quantities gives us the above 300942.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 39.9x | 36.1x |
| Forward P/E multiples | 11.0x - 12.7x | 11.4x |
| Fair Price | 1.55 - 5.14 | 3.22 |
| Upside | -78.4% - -28.6% | -55.2% |
| Date | EV/EBITDA |
| 2026-05-22 | 128.79 |
| 2026-05-21 | 126.56 |
| 2026-05-20 | 130.85 |
| 2026-05-19 | 133.59 |
| 2026-05-18 | 133.59 |
| 2026-05-15 | 132.56 |
| 2026-05-14 | 134.11 |
| 2026-05-13 | 136.68 |
| 2026-05-12 | 137.19 |
| 2026-05-11 | 142.86 |
| 2026-05-08 | 140.11 |
| 2026-05-07 | 138.91 |
| 2026-05-06 | 138.05 |
| 2026-04-30 | 140.11 |
| 2026-04-29 | 140.11 |
| 2026-04-28 | 137.54 |
| 2026-04-27 | 140.28 |
| 2026-04-24 | 147.15 |
| 2026-04-23 | 144.74 |
| 2026-04-22 | 146.97 |
| 2026-04-21 | 148.00 |
| 2026-04-20 | 148.69 |
| 2026-04-17 | 148.52 |
| 2026-04-16 | 151.26 |
| 2026-04-15 | 149.55 |
| 2026-04-14 | 150.06 |
| 2026-04-13 | 153.84 |
| 2026-04-10 | 148.35 |
| 2026-04-09 | 146.46 |
| 2026-04-08 | 151.09 |
| 2026-04-07 | 147.49 |
| 2026-04-03 | 142.68 |
| 2026-04-02 | 149.03 |
| 2026-04-01 | 152.29 |
| 2026-03-31 | 148.86 |
| 2026-03-30 | 150.92 |
| 2026-03-27 | 151.61 |
| 2026-03-26 | 147.83 |
| 2026-03-25 | 150.58 |
| 2026-03-24 | 151.44 |
| 2026-03-23 | 143.20 |
| 2026-03-20 | 155.55 |
| 2026-03-19 | 162.93 |
| 2026-03-18 | 167.74 |
| 2026-03-17 | 164.31 |
| 2026-03-16 | 169.11 |
| 2026-03-13 | 168.25 |
| 2026-03-12 | 168.77 |
| 2026-03-11 | 169.62 |
| 2026-03-10 | 171.34 |